-
公开(公告)号:US11647959B2
公开(公告)日:2023-05-16
申请号:US16958165
申请日:2019-01-02
Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventor: Duxin Sun , Yogesh B. Gianchandani , Tao Li , Jinhui Liao , Qisen Cheng , Johnathan Lewis , Ryan Meredith , Jeremy Felton
CPC classification number: A61B5/6861 , A61B5/01 , A61B5/036 , A61B5/073 , A61B5/14539 , A61B10/0045 , A61B5/4255 , A61B2010/0061 , A61B2560/0214 , A61B2562/06 , A61B2562/162
Abstract: An ingestible electronic capsule for the collection of samples along a gastric intestinal tract and methods relating thereto are provided. The ingestible electronic capsule includes a housing and a cap that form an interior chamber. The cap includes a sampling port and one or more sample collection chambers are disposed within the interior chamber. A motor is also disposed within the interior chamber and is configured to rotate one of the cap and the one or more sample collection chambers so to align one or the one or more sample collection chambers and the sampling port of the cap so to allow for sample collection. A microcontroller is also disposed within the interior chamber and is in communication with at least the motor. The microcontroller is configured to control the selective alignment of the sampling port and one of the one or more sample collection chambers and induce gastric intestinal fluid sampling.
-
公开(公告)号:US20210346478A1
公开(公告)日:2021-11-11
申请号:US17232751
申请日:2021-04-16
Applicant: The Regents of the University of Michigan
Inventor: Duxin Sun , Ryan Clauson , Hongwei Chen , Chengyi Li , Wei Gao , Luke Bugada , Fei Wen , Brett Hill , Syed Monem Rizvi
IPC: A61K39/00 , A61K47/02 , A61K9/16 , A61K38/19 , A61K47/69 , A61K47/64 , A61K45/06 , A61K39/295 , A61P35/00 , A61K39/39
Abstract: The present invention provides, in some embodiments, methods, compositions, systems, and kits comprising nano-satellite complexes comprising: a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core; 3-25 satellite particles attached to, or absorbed to, said biocompatible coating; a plurality of antigenic peptides conjugated to, or absorbed to, said satellite particles; and at least one additional property. In other embodiments, provided herein are nano-satellite complexes comprising: a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core; a plurality of satellite particles attached to, or absorbed to, said biocompatible coating; a plurality of antigenic peptides conjugated to, or absorbed to, said satellite particles; and a plurality of LIGHT (TNFSF14) peptides conjugated to, or absorbed to, said satellite particles. In some embodiments, administration of the nanosatellite complexes to a subject with cancer achieves long-term cancer remission (e.g., when combined with an immune checkpoint inhibitor, such as αPD1).
-
公开(公告)号:US20170210761A1
公开(公告)日:2017-07-27
申请号:US15443336
申请日:2017-02-27
Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventor: Shaomeng Wang , Yujun Zhao , Bing Zhou , Angelo Aguilar , Liu Liu , Longchuan Bai , Donna McEachern , Duxin Sun , Bo Wen , Ruijuan Luo , Ting Zhao , Arul Chinnaiyan , Irfan A. Asangani , Jeanne Stuckey , Jennifer Lynn Meagher , Xu Ran , Yang Hu
IPC: C07D519/00 , A61K31/519 , C07D487/14 , A61K31/538 , A61K31/437 , C07D487/04 , A61K31/5377
CPC classification number: C07D519/00 , A61K31/437 , A61K31/519 , A61K31/5377 , A61K31/538 , C07D487/04 , C07D487/14
Abstract: The present disclosure provides substituted 9H-pyrimido[4,5-b]indoles and 5H-pyrido[4,3-b]indoles and related analogs represented by Formula I: and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R1a, A, B1, B2, G, X1, Y1, Y2, and Y3 are as defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a condition or disorder responsive to inhibition of BET bromodomains. Compounds of the present disclosure are especially useful for treating cancer.
-
公开(公告)号:US09533045B2
公开(公告)日:2017-01-03
申请号:US14457650
申请日:2014-08-12
Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventor: Hongwei Chen , Duxin Sun
CPC classification number: A61K41/0052 , A61K33/26 , A61N5/062 , A61N2005/0659 , A61N2005/0662
Abstract: The present invention provides methods, systems, and devices for performing photothermal therapy (e.g., to treat cancer) using photothermal nanoparticles with a biocompatible coating surrounding a highly crystallized Fe3O4 core. In certain embodiments, the highly crystallized Fe3O4 core of the photothermal nanoparticles has an X-ray diffraction (XRD) pattern where the brightest diffraction ring is from the 440 plane. In some embodiments, the photothermal therapy is conducted with a device configured to emit electromagnetic radiation in the wavelengths between about 650 nm and 1000 nm, wherein the device further comprises a visible light source that allows a user to determine where the electromagnetic radiation is contacting a subject.
Abstract translation: 本发明提供了使用具有围绕高度结晶的Fe 3 O 4核心的生物相容性涂层的光热纳米颗粒进行光热治疗(例如治疗癌症)的方法,系统和装置。 在某些实施方案中,光热纳米颗粒的高度结晶的Fe 3 O 4核心具有X射线衍射(XRD)图案,其中最亮的衍射环来自440平面。 在一些实施例中,光热疗法是用配置成发射大约650nm和1000nm之间的波长的电磁辐射的装置进行的,其中所述装置还包括允许用户确定电磁辐射在哪里接触的可见光源 学科。
-
25.
公开(公告)号:US09505782B2
公开(公告)日:2016-11-29
申请号:US14937421
申请日:2015-11-10
Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventor: Jolanta Grembecka , Tomasz Cierpicki , Dmitry Borkin , Jay L. Hess , Duxin Sun , Xiaoqin Li
IPC: C07D495/04 , C07D495/16 , C07D519/00
CPC classification number: C07D495/04 , C07D495/16 , C07D519/00
Abstract: The present disclosure relates generally to thienopyrimidine and thienopyridine compounds and methods of use thereof. In particular embodiments, the present disclosure provides compositions comprising thienopyrimidine and thienopyridine compounds of Formula 2: and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.
-
公开(公告)号:US20140378680A1
公开(公告)日:2014-12-25
申请号:US14485054
申请日:2014-09-12
Applicant: The Regents of the University of Michigan
Inventor: Shaomeng Wang , Shanghai Yu , Wei Sun , SanJeev Kumar , Duxin Sun , Peng Zou , Donna McEachern , Yujun Zhao
IPC: C07D487/10 , C07D471/20 , C07F9/6561
CPC classification number: C07D487/10 , A61K31/407 , A61K31/454 , A61K31/496 , A61K31/5377 , A61K31/675 , A61K45/06 , C07D471/20 , C07D491/107 , C07D495/10 , C07F9/6561 , A61K2300/00
Abstract: Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as therapeutics for the treatment of cancer and other diseases.
-
公开(公告)号:US20140296551A1
公开(公告)日:2014-10-02
申请号:US14212594
申请日:2014-03-14
Inventor: Duxin Sun , Hongwei Chen , Wei Qian , Yong Che , Masayuki Ito , Hayley Paholak , Kanokwan Sansanaphongpricha
IPC: C08G65/48
CPC classification number: C08G65/48 , A61K41/0052 , A61K47/50 , A61K47/60 , A61K49/0065 , C08G65/3344
Abstract: The present invention relates to methods, compositions, and kits for generating conjugated gold nanoparticles. In certain embodiments, the present invention provides methods of generating unsaturated conjugated gold nanoparticles by mixing naked gold nanoparticles with a first type of attachment molecules at a molar ratio such that the attachment molecules attach to the naked gold particles at a density level below the saturation level of the naked gold particles (e.g., at a saturation level of 1-99%). In some embodiments, a second type of attachment molecules (e.g., with the opposite charge as the first type of attachment molecules) are mixed with the unsaturated conjugated gold nanoparticles to generate double-conjugated gold nanoparticles (e.g., that are zwitterionic)
Abstract translation: 本发明涉及用于产生共轭金纳米颗粒的方法,组合物和试剂盒。 在某些实施方案中,本发明提供了通过将裸金纳米颗粒与第一类型附着分子以摩尔比混合以使得附着分子以低于饱和水平的密度水平附着于裸金颗粒的方式来产生不饱和共轭金纳米颗粒的方法 的裸金粒子(例如,在1-99%的饱和度水平)。 在一些实施方案中,将第二类型的附着分子(例如,具有相反电荷作为第一类型的附着分子)与不饱和共轭金纳米颗粒混合以产生双共轭金纳米颗粒(例如,两性离子)
-
公开(公告)号:US10898595B2
公开(公告)日:2021-01-26
申请号:US16694715
申请日:2019-11-25
Applicant: The Regents of the University of Michigan
Inventor: Hongwei Chen , Duxin Sun
Abstract: The present invention provides methods, compositions, systems, and kits comprising core-satellite nanocomposites useful for photothermal and/or MRI applications (e.g., tumor treatment and/or imaging). In certain embodiments, the core-satellite nanocomposites comprise: i) a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core, and ii) at least one satellite component attached to, or absorbed to, the biocompatible coating. In some embodiments, the nanoparticle core and satellite component are composed of near-infrared photothermal agent material and/or MRI contrast agent material. In further embodiments, the satellite component is additionally or alternatively composed of near-infrared optical dye material.
-
公开(公告)号:US10202340B2
公开(公告)日:2019-02-12
申请号:US15546320
申请日:2016-02-01
Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventor: Scott D. Larsen , Akira Abe , Liming Shu , Michael William Wilson , Richard F. Keep , Duxin Sun , James A. Shayman
IPC: A61K31/4015 , C07D207/06 , C07D263/20 , C07D207/04 , C07D263/24 , C07D205/04 , C07D207/09 , C07D207/10 , C07D295/125 , C07D295/13
Abstract: Glucosylceramide synthase inhibitors and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
-
公开(公告)号:US20180256757A1
公开(公告)日:2018-09-13
申请号:US15972674
申请日:2018-05-07
Applicant: The Regents of the University of Michigan
Inventor: Hongwei Chen , Duxin Sun
CPC classification number: A61K49/1824 , A61B5/0035 , A61B5/0075 , A61B5/055 , A61K41/0052 , A61K49/1827 , A61K49/183 , A61K49/1833 , A61K49/1851 , A61N5/062 , A61N2005/0659 , G01R33/4808 , G01R33/5601
Abstract: The present invention provides methods, compositions, systems, and kits comprising core-satellite nanocomposites useful for photothermal and/or MRI applications (e.g., tumor treatment and/or imaging). In certain embodiments, the core-satellite nanocomposites comprise: i) a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core, and ii) at least one satellite component attached to, or absorbed to, the biocompatible coating. In some embodiments, the nanoparticle core and satellite component are composed of near-infrared photothermal agent material and/or MRI contrast agent material. In further embodiments, the satellite component is additionally or alternatively composed of near-infrared optical dye material.
-
-
-
-
-
-
-
-
-